204 related articles for article (PubMed ID: 25283553)
1. Inhibition of the ANT(2")-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic α-hydroxytropolones.
Hirsch DR; Cox G; D'Erasmo MP; Shakya T; Meck C; Mohd N; Wright GD; Murelli RP
Bioorg Med Chem Lett; 2014 Nov; 24(21):4943-7. PubMed ID: 25283553
[TBL] [Abstract][Full Text] [Related]
2. Structural and molecular basis for resistance to aminoglycoside antibiotics by the adenylyltransferase ANT(2″)-Ia.
Cox G; Stogios PJ; Savchenko A; Wright GD
mBio; 2015 Jan; 6(1):. PubMed ID: 25564464
[TBL] [Abstract][Full Text] [Related]
3. New inhibitors for aminoglycoside-adenylyltransferase.
Saleh NA; Zwiefak A; Peczyńska-Czoch W; Mordarski M; Pulverer G
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):66-75. PubMed ID: 2851905
[TBL] [Abstract][Full Text] [Related]
4. 7-Hydroxytropolone: an inhibitor of aminoglycoside-2"-O-adenylyltransferase.
Allen NE; Alborn WE; Hobbs JN; Kirst HA
Antimicrob Agents Chemother; 1982 Nov; 22(5):824-31. PubMed ID: 6185088
[TBL] [Abstract][Full Text] [Related]
5. Relation between aminoglycoside 2"-O-nucleotidyltransferase activity and aminoglycoside resistance.
Bongaerts GP; Molendijk L
Antimicrob Agents Chemother; 1984 Feb; 25(2):234-7. PubMed ID: 6324668
[TBL] [Abstract][Full Text] [Related]
6. ANT(9)-Ic, a Novel Chromosomally Encoded Aminoglycoside Nucleotidyltransferase from Brucella intermedia.
Sheng X; Lu W; Li A; Lu J; Song C; Xu J; Dong Y; Fu C; Lin X; Zhu M; Bao Q; Li K
Microbiol Spectr; 2023 Jun; 11(3):e0062023. PubMed ID: 37039640
[TBL] [Abstract][Full Text] [Related]
7. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
Fernández-Martínez M; Miró E; Ortega A; Bou G; González-López JJ; Oliver A; Pascual A; Cercenado E; Oteo J; Martínez-Martínez L; Navarro F;
Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
[TBL] [Abstract][Full Text] [Related]
8. Structural Analysis of the Tobramycin and Gentamicin Clinical Resistome Reveals Limitations for Next-generation Aminoglycoside Design.
Bassenden AV; Rodionov D; Shi K; Berghuis AM
ACS Chem Biol; 2016 May; 11(5):1339-46. PubMed ID: 26900880
[TBL] [Abstract][Full Text] [Related]
9. Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance.
Stogios PJ; Spanogiannopoulos P; Evdokimova E; Egorova O; Shakya T; Todorovic N; Capretta A; Wright GD; Savchenko A
Biochem J; 2013 Sep; 454(2):191-200. PubMed ID: 23758273
[TBL] [Abstract][Full Text] [Related]
10. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
Xiao Y; Hu Y
Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
[TBL] [Abstract][Full Text] [Related]
11. Cloning, overexpression, and purification of aminoglycoside antibiotic nucleotidyltransferase (2'')-Ia: conformational studies with bound substrates.
Ekman DR; DiGiammarino EL; Wright E; Witter ED; Serpersu EH
Biochemistry; 2001 Jun; 40(24):7017-24. PubMed ID: 11401545
[TBL] [Abstract][Full Text] [Related]
12. Aminoglycoside resistance patterns in Turkey.
Akalin HE; Torun M; Alacam R
Scand J Infect Dis; 1988; 20(2):199-203. PubMed ID: 2840733
[TBL] [Abstract][Full Text] [Related]
13. Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.
Jacoby GA; Blaser MJ; Santanam P; Hächler H; Kayser FH; Hare RS; Miller GH
Antimicrob Agents Chemother; 1990 Dec; 34(12):2381-6. PubMed ID: 1965106
[TBL] [Abstract][Full Text] [Related]
14. Characterization of aminoglycoside resistance genes and class 1 integrons in porcine and bovine gentamicin-resistant Escherichia coli.
Sandvang D; Aarestrup FM
Microb Drug Resist; 2000; 6(1):19-27. PubMed ID: 10868804
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of a novel inhibitor of an aminoglycoside-inactivating enzyme.
Kirst HA; Marconi GG; Counter FT; Ensminger PW; Jones ND; Chaney MO; Toth JE; Allen NE
J Antibiot (Tokyo); 1982 Dec; 35(12):1651-7. PubMed ID: 6300011
[TBL] [Abstract][Full Text] [Related]
16. [Aminoglycoside resistance in gramnegative pathogens of nosocomial infections in Russia].
Reshed'ko GK
Antibiot Khimioter; 2004; 49(5):11-23. PubMed ID: 15573898
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis of enzymatic resistance of E. coli to aminoglycosides.
Ojdana D; Sieńko A; Sacha P; Majewski P; Wieczorek P; Wieczorek A; Tryniszewska E
Adv Med Sci; 2018 Mar; 63(1):9-13. PubMed ID: 28763677
[TBL] [Abstract][Full Text] [Related]
18. Selective modification of the 3''-amino group of kanamycin prevents significant loss of activity in resistant bacterial strains.
Santana AG; Zárate SG; Asensio JL; Revuelta J; Bastida A
Org Biomol Chem; 2016 Jan; 14(2):516-525. PubMed ID: 26501183
[TBL] [Abstract][Full Text] [Related]
19. Detection of a novel aph(2") allele (aph[2"]-Ie) conferring high-level gentamicin resistance and a spectinomycin resistance gene ant(9)-Ia (aad 9) in clinical isolates of enterococci.
Mahbub Alam M; Kobayashi N; Ishino M; Sumi A; Kobayashi K; Uehara N; Watanabe N
Microb Drug Resist; 2005; 11(3):239-47. PubMed ID: 16201926
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of affinity for aminoglycoside binding to the aminoglycoside nucleotidyltransferase(2'')-Ia.
Wright E; Serpersu EH
Biochemistry; 2006 Aug; 45(34):10243-50. PubMed ID: 16922499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
